BW
IHE icon

Bravera Wealth’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bravera Wealth’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.11K Hold
92
– – ﹤0.01% 279
2026
Q1 		$7.97K Hold
92
– – ﹤0.01% 310
2025
Q4 		$7.8K Buy
+92
New +$7.34K ﹤0.01% 298

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

Bravera Wealth's IHE Position: Q2 2026 in Review

Bravera Wealth held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 92 shares worth $9.11K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

Bravera Wealth first reported a position in IHE in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Bravera Wealth held 92 shares of iShares US Pharmaceuticals ETF worth $9.11K as of Q2 2026.
  • Bravera Wealth left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Bravera Wealth's portfolio in Q2 2026, its #279 holding.
  • Bravera Wealth first reported a position in iShares US Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.